Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00366002
Status:
COMPLETED
Last Update Posted:
2008-01-15
First Post:
2006-08-17
Brief Title:
Patients Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Overactive Bladder OAB |
Keywords:
| Name | View |
|---|---|
| DarifenacinOveractive BladderantimuscarinicM3 muscarinic receptor antagonist | View |